Cerevel Therapeutics Hldg Inc
(CERE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -351,511 | -258,703 | -158,765 | -68,294 | -225,334 |
| Depreciation Amortization | -1,646 | 2,682 | 3,353 | 1,671 | 2,753 |
| Accounts payable and accrued liabilities | -763 | 4,237 | 464 | -2,499 | 7,278 |
| Other Working Capital | 28,064 | 20,631 | 17,697 | -5,407 | 15,541 |
| Other Operating Activity | 32,669 | 25,444 | 11,947 | 6,881 | 21,216 |
| Operating Cash Flow | $-293,187 | $-205,709 | $-125,304 | $-67,648 | $-178,546 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -384,880 | -358,602 | 29,081 | -36,345 | -425,158 |
| PPE Investments | -3,954 | -3,500 | -3,329 | -2,197 | -10,503 |
| Investing Cash Flow | $-388,834 | $-362,102 | $25,752 | $-38,542 | $-435,661 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 334,774 | 353,587 | N/A | N/A | N/A |
| Common Stock Issued | 251,315 | 248,974 | 5,170 | 2,854 | 392,707 |
| Other Financing Activity | 37,102 | 18,499 | 37,249 | -251 | 30,895 |
| Financing Cash Flow | $623,191 | $621,060 | $42,419 | $2,603 | $423,602 |
| Beginning Cash Position | 197,218 | 197,218 | 197,218 | 197,218 | 387,823 |
| End Cash Position | 138,388 | 250,467 | 140,085 | 93,631 | 197,218 |
| Net Cash Flow | $-58,830 | $53,249 | $-57,133 | $-103,587 | $-190,605 |
| Free Cash Flow | |||||
| Operating Cash Flow | -293,187 | -205,709 | -125,304 | -67,648 | -178,546 |
| Capital Expenditure | -3,954 | -3,500 | -3,329 | -2,197 | -10,503 |
| Free Cash Flow | -297,141 | -209,209 | -128,633 | -69,845 | -189,049 |